These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
247 related articles for article (PubMed ID: 23592914)
21. Sildenafil attenuates vaso-obliteration and neovascularization in a mouse model of retinopathy of prematurity. Fawzi AA; Chou JC; Kim GA; Rollins SD; Taylor JM; Farrow KN Invest Ophthalmol Vis Sci; 2014 Mar; 55(3):1493-501. PubMed ID: 24519428 [TBL] [Abstract][Full Text] [Related]
22. Relationship between Pericytes and Endothelial Cells in Retinal Neovascularization: A Histological and Immunofluorescent Study of Retinal Angiogenesis. Choi SH; Chung M; Park SW; Jeon NL; Kim JH; Yu YS Korean J Ophthalmol; 2018 Feb; 32(1):70-76. PubMed ID: 29376221 [TBL] [Abstract][Full Text] [Related]
23. Involvement of Nox2 NADPH oxidase in retinal neovascularization. Chan EC; van Wijngaarden P; Liu GS; Jiang F; Peshavariya H; Dusting GJ Invest Ophthalmol Vis Sci; 2013 Oct; 54(10):7061-7. PubMed ID: 24106122 [TBL] [Abstract][Full Text] [Related]
24. HIF-2alpha-haploinsufficient mice have blunted retinal neovascularization due to impaired expression of a proangiogenic gene battery. Dioum EM; Clarke SL; Ding K; Repa JJ; Garcia JA Invest Ophthalmol Vis Sci; 2008 Jun; 49(6):2714-20. PubMed ID: 18281611 [TBL] [Abstract][Full Text] [Related]
25. Hypericin inhibits pathological retinal neovascularization in a mouse model of oxygen-induced retinopathy. Higuchi A; Yamada H; Yamada E; Jo N; Matsumura M Mol Vis; 2008 Feb; 14():249-54. PubMed ID: 18334941 [TBL] [Abstract][Full Text] [Related]
26. β‑elemene inhibits oxygen‑induced retinal neovascularization via promoting miR‑27a and reducing VEGF expression. Zhang W; Chen L; Geng J; Liu L; Xu L Mol Med Rep; 2019 Mar; 19(3):2307-2316. PubMed ID: 30664207 [TBL] [Abstract][Full Text] [Related]
27. Retro-orbital injection of FITC-dextran is an effective and economical method for observing mouse retinal vessels. Li S; Li T; Luo Y; Yu H; Sun Y; Zhou H; Liang X; Huang J; Tang S Mol Vis; 2011; 17():3566-73. PubMed ID: 22219652 [TBL] [Abstract][Full Text] [Related]
28. Spatial pattern and temporal evolution of retinal oxygenation response in oxygen-induced retinopathy. Roberts R; Zhang W; Ito Y; Berkowitz BA Invest Ophthalmol Vis Sci; 2003 Dec; 44(12):5315-20. PubMed ID: 14638732 [TBL] [Abstract][Full Text] [Related]
29. The effect of thalidomide on neovascularization in a mouse model of retinopathy of prematurity. Rabinowitz R; Katz G; Rosner M; Pri-Chen S; Spierer A Graefes Arch Clin Exp Ophthalmol; 2008 Jun; 246(6):843-8. PubMed ID: 18343940 [TBL] [Abstract][Full Text] [Related]
30. Neuropeptide Y expression in a mouse model of oxygen-induced retinopathy. Yoon HZ; Yan Y; Geng Y; Higgins RD Clin Exp Ophthalmol; 2002 Dec; 30(6):424-9. PubMed ID: 12427234 [TBL] [Abstract][Full Text] [Related]
31. Hyperoxia causes reduced density of retinal astrocytes in the central avascular zone in the mouse model of oxygen-induced retinopathy. Bucher F; Stahl A; Agostini HT; Martin G Mol Cell Neurosci; 2013 Sep; 56():225-33. PubMed ID: 23756201 [TBL] [Abstract][Full Text] [Related]
32. Role of hypoxia-inducible factor-1α and survivin in oxygen-induced retinopathy in mice. Liu N; Sun Y; Zhao N; Chen L Int J Clin Exp Pathol; 2014; 7(10):6814-9. PubMed ID: 25400763 [TBL] [Abstract][Full Text] [Related]
33. Expression and activation of STAT3 in ischemia-induced retinopathy. Mechoulam H; Pierce EA Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4409-16. PubMed ID: 16303927 [TBL] [Abstract][Full Text] [Related]
34. RhoA activation and effect of Rho-kinase inhibitor in the development of retinal neovascularization in a mouse model of oxygen-induced retinopathy. Fang X; Ueno M; Yamashita T; Ikuno Y Curr Eye Res; 2011 Nov; 36(11):1028-36. PubMed ID: 21999228 [TBL] [Abstract][Full Text] [Related]
35. CCR7/p-ERK1/2/VEGF signaling promotes retinal neovascularization in a mouse model of oxygen-induced retinopathy. Yuan LH; Chen XL; Di Y; Liu ML Int J Ophthalmol; 2017; 10(6):862-869. PubMed ID: 28730075 [TBL] [Abstract][Full Text] [Related]
36. Correspondence of retinal thinning and vasculopathy in mice with oxygen-induced retinopathy. Mezu-Ndubuisi OJ; Wanek J; Chau FY; Teng PY; Blair NP; Reddy NM; Raj JU; Reddy SP; Shahidi M Exp Eye Res; 2014 May; 122():119-22. PubMed ID: 24703909 [TBL] [Abstract][Full Text] [Related]
37. CEACAM1 confers resistance toward oxygen-induced vessel damage in a mouse model of retinopathy of prematurity. Ludewig P; Flachsbarth K; Wegscheid C; Tiegs G; Richard G; Wagener C; Bartsch U; Horst AK Invest Ophthalmol Vis Sci; 2014 Nov; 55(12):7950-60. PubMed ID: 25406283 [TBL] [Abstract][Full Text] [Related]
38. Norrin treatment improves ganglion cell survival in an oxygen-induced retinopathy model of retinal ischemia. Dailey WA; Drenser KA; Wong SC; Cheng M; Vercellone J; Roumayah KK; Feeney EV; Deshpande M; Guzman AE; Trese M; Mitton KP Exp Eye Res; 2017 Nov; 164():129-138. PubMed ID: 28823941 [TBL] [Abstract][Full Text] [Related]
39. Activation of retinal microglia rather than microglial cell density correlates with retinal neovascularization in the mouse model of oxygen-induced retinopathy. Fischer F; Martin G; Agostini HT J Neuroinflammation; 2011 Sep; 8():120. PubMed ID: 21943408 [TBL] [Abstract][Full Text] [Related]
40. A murine model for retinopathy of prematurity identifies endothelial cell proliferation as a potential mechanism for plus disease. Guaiquil VH; Hewing NJ; Chiang MF; Rosenblatt MI; Chan RV; Blobel CP Invest Ophthalmol Vis Sci; 2013 Aug; 54(8):5294-302. PubMed ID: 23833070 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]